» Articles » PMID: 17221881

Intraepidermal Nerve Fiber Density As a Marker of Early Diabetic Neuropathy

Overview
Journal Muscle Nerve
Date 2007 Jan 16
PMID 17221881
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of the study was to reliably identify an early stage of diabetic polyneuropathy (DPN) by measuring injury to epidermal nerve fibers. We compared intraepidermal nerve fiber density (IENFD) at the ankle and thigh of 29 diabetic subjects who had no clinical or electrophysiological evidence of small- or large-fiber neuropathy to that of 84 healthy controls. The mean ankle IENFD of diabetic subjects was 9.1+/-5.0 mm and that of controls, 13.0+/-4.8 mm (P<0.001). The thigh IENFD did not differ significantly. The IENFD ratio (thigh IENFD divided by ankle IENFD) was 2.39+/-1.30 in diabetic subjects and 1.77+/-0.58 in controls (P<0.001), indicating a length-dependent reduction of IENFD in diabetics. Ankle IENFD remained significantly lower and the IENFD ratio higher in diabetic subjects after adjusting for age. Two subjects had parasympathetic dysfunction, two had retinopathy, and two early nephropathy. Age, height, weight, duration of diabetes, and average HbA1c did not influence IENFD among diabetic subjects. We used receiver operating characteristic (ROC) curves to describe and compare the utility of various threshold values of ankle IENFD and IENFD ratio for the diagnosis of early DPN. The sensitivity and specificity of diagnosing DPN using ankle IENFD of less than 10 mm were 72.4% and 76.2%, respectively. Thus, asymptomatic diabetics have a measurable, length-dependent reduction of distal epidermal nerves. Analogous to microalbuminuria in diabetic nephropathy, reliable identification and quantitation of nascent diabetic neuropathy may have potential therapeutic implications.

Citing Articles

Foot screening and customized health education program for patients with diabetic peripheral neuropathy: A nurse-led, real-world observational study.

Liu S, Ding H, Li D, Lu F, Luo G, He Y Int J Nurs Stud Adv. 2025; 8:100291.

PMID: 39896918 PMC: 11787437. DOI: 10.1016/j.ijnsa.2025.100291.


Assessment of intraepidermal nerve fiber densities in 5 µm sections from arm and leg - a search for normative age-related values.

Ekman L, Dahlin L, Englund E Free Neuropathol. 2024; 5:24.

PMID: 39416858 PMC: 11481297. DOI: 10.17879/freeneuropathology-2024-5815.


Antioxidant Effect in Diabetic Peripheral Neuropathy in Rat Model: A Systematic Review.

Rusli N, Ng C, Makpol S, Wong Y, Mohd Isa I, Remli R Antioxidants (Basel). 2024; 13(9).

PMID: 39334700 PMC: 11428735. DOI: 10.3390/antiox13091041.


Diabetic Peripheral Neuropathy: Emerging Treatments of Neuropathic Pain and Novel Diagnostic Methods.

Roikjer J, Borbjerg M, Andresen T, Giordano R, Hviid C, Morch C J Diabetes Sci Technol. 2024; :19322968241279553.

PMID: 39282925 PMC: 11571639. DOI: 10.1177/19322968241279553.


Origin, identity, and function of terminal Schwann cells.

Hastings R, Valdez G Trends Neurosci. 2024; 47(6):432-446.

PMID: 38664109 PMC: 11168889. DOI: 10.1016/j.tins.2024.03.007.